v3.26.3
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2024
Jun. 30, 2026
Jun. 30, 2025
Sep. 24, 2024
Dec. 31, 2025
Income Statement [Abstract]              
Revenue $ 1,587 $ 465 $ 3,056 $ 4,215
Cost of revenue 722 2,072 1,400 1,873
Gross profit 865 (1,607) 1,656 2,342
Selling, general and administrative expenses 26,187 21,331 26,462 114,723 51,490 76,872 147,694
Payroll expense 414,186 489,114 578,100 1,514,886 856,147 334,644 2,008,394
Professional service fees 198,364 75,003 116,652 730,627 142,945 243,057 931,279
Impairment loss on Intellectual property         2,550,000
Depreciation and amortization 75,000 150,000 150,000 300,000
Total operating expenses 638,737 660,448 871,214 2,360,236 1,200,582 654,573 5,937,367
Operating loss (638,737) (659,583) (872,821) (2,360,236) (1,198,926) (654,573) (5,935,025)
Other income (loss) 50 (1,000) 62 1,000
Impairment loss on investment         (500,000)
Gain on debt settlement         175,000
Interest income (expense), net (39) 10,030 (287,028) (427) (67) (19,166)
Total other income (expense) 11 (1,000) 10,030 (286,966) (427) (67) (343,166)
Net loss (638,726) (660,583) $ (862,791) (2,647,202) (1,199,353) $ (654,640) $ (6,278,191)
Accretion to redeemable preferred equity 217,753   2,062,360    
Dividends on Series A preferred stock 78,540   88,508    
Net Loss attributable to common stockholders $ (935,019) $ (660,583)   $ (4,798,070) $ (1,199,353)    
Net loss per share:              
Net loss per share attributable to common stockholders - basic $ (0.10) $ (0.05) $ (0.07) $ (0.41) $ (0.09)   $ (0.46)
Net loss per share attributable to common stockholders - diluted $ (0.10) $ (0.05) $ (0.07) $ (0.41) $ (0.09)   $ (0.46)
Weighted average shares outstanding:              
Weighted average shares outstanding - basic 8,994,253 13,336,471 13,089,592 11,705,727 [1] 13,276,331 [1]   13,565,096
Weighted average shares outstanding - diluted 8,994,253 13,336,471 13,089,592 11,705,727 [1] 13,276,331 [1]   13,565,096
[1] Due to the anti-dilutive effect, the computation of basic and diluted EPS did not include the shares underlying the exercise of warrants, options, RSUs and Series A preferred stock as the Company had a net loss for the three and six months ended June 30, 2026 and 2025.